Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN

ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE

Standard Dose
325MG;100MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 076743 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE Form and strength TABLET;ORAL - 325MG;100MG Sponsor CORNERSTONE Submission history Latest submission status date: 2004-05-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 076743 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE Form and strength TABLET;ORAL - 325MG;100MG Sponsor CORNERSTONE Submission history Latest submission status date: 2004-05-07 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN (ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE) | Drug Monograph | MedicHelpline